Steven Hale, MD
Orthopaedic Surgery · Lake Charles, LANPI 1205059763
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,570 of the $3,975 with a category attached, or 64.7%. Stryker accounts for 82.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $1,844 and has fallen 69.6% since, to $562 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in LA, where the typical reported total is $3,274.
Across 46 payments — averaging $86.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Arthrex$205
- Curonix LLC$141
- Smith+Nephew$106
- ALON Medical Technology$82
- AbbVie$79
- plus $75 from 2 others
What the payments were for
- Travel & lodging$2,57065%
- Food & beverage$1,40535%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 21 | $3,287 |
| Arthrex | 12 | $205 |
| Curonix LLC | 2 | $141 |
| Smith+Nephew | 2 | $106 |
| ALON Medical Technology | 1 | $82 |
| AbbVie | 5 | $79 |
| Johnson & Johnson(2 entities) | 2 | $59 |
| Vericel Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,883
How this compares
$3,975 in reported general payments places this provider in the 50th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 90 | $533 |
| Meloxicam | 81 | $215 |
| Diclofenac Sodium | 11 | $158 |
| Celecoxib | 16 | $142 |
| Tramadol Hcl | 56 | $138 |
| Methylprednisolone | 21 | $137 |
| Amoxicillin | 54 | $91 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $85 |
| Gabapentin | 13 | $67 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $64 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Lake Charles
- Thomas AxelradLake Charles$75K
- Michael GarittyLake Charles$30K
- James JacksonLake Charles$26K
- Christopher HarrodBaton Rouge$3M
- Vinod DasaKenner$1.9M
- Pierce NunleyShreveport$1.8M
- Jorge IsazaBaton Rouge$1.2M
- Neil MakiThibodaux$620K
- Robert ZuraNew Orleans$597K
- Kevin McCarthyBaton Rouge$594K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.